Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on September 11, 2026

Sep. 11, 2026

Kaplan Fox Advises Planet Fitness, Inc. (NYSE: PLNT) Investors to Act Before the Lead Plaintiff Deadline on September 14, 2026

Indeterminate GlobeNewswire

Sep. 11, 2026

Chengde Releases Four Premium Inbound Tourism Routes, Creating a Worry-Free, Secure and Comfortable International Journey with Thoughtful Amenities

Indeterminate GlobeNewswire

Sep. 11, 2026

Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 11, 2026

REPEAT – Media Advisory: Capital Power and Alpine Canada, joined by the Government of Canada, to make major announcement on the future of Canadian winter sport

Indeterminate GlobeNewswire

Sep. 11, 2026

Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA

Indeterminate GlobeNewswire

Sep. 11, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System

Indeterminate GlobeNewswire

Sep. 11, 2026

Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand

Indeterminate GlobeNewswire

Sep. 11, 2026

Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand

Indeterminate GlobeNewswire

Sep. 11, 2026

Mark Holland se joint à la Fondation pour la santé des hommes au Canada à titre de l’un de ses nouveaux membres du conseil d’administration

Indeterminate GlobeNewswire

Sep. 11, 2026

Mark Holland Joins Canadian Men’s Health Foundation As One Of Its Newest Board Members

Indeterminate GlobeNewswire

Sep. 11, 2026

LULU Investigation Reminder: Lululemon Securities Fraud Investigation to Recover Losses is Pending – Investors Notified to Contact BFA Law

Indeterminate GlobeNewswire

Sep. 11, 2026

Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress

Indeterminate GlobeNewswire

Sep. 11, 2026

MemoVolt Launch 2026: New Natural Dual-Action Brain and Memory Support Formula Read MemoVolt Brain Supplement Facts & Ingredients Highlights.

Indeterminate GlobeNewswire

Sep. 11, 2026

Sports Event City, Connecting the World: Beijing Accelerates Building a World-Class Sports Host City

Indeterminate GlobeNewswire

Sep. 11, 2026

Resolution Therapeutics completes enrollment in Phase I/II EMERALD clinical trial evaluating RTX001 in end-stage liver disease

Indeterminate GlobeNewswire

Sep. 11, 2026

The 2026 CIFTIS Appointment: A World Symphony of Shared Benefits and Joint Progress

Indeterminate GlobeNewswire

Sep. 11, 2026

Persica Pharmaceuticals publishes new analysis of assay sensitivity in disc microbiology studies, reinforcing the potential for PP353 in vertebrogenic Lumbar Back Pain

Indeterminate GlobeNewswire

Sep. 11, 2026

GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris

Indeterminate GlobeNewswire

Sep. 11, 2026

GENFIT va intégrer les indices CAC Mid 60 et SBF 120 d’Euronext Paris

Indeterminate GlobeNewswire

Sep. 11, 2026

Nicox Announces NCX 470 NDA in China Accepted for Review

Indeterminate GlobeNewswire